Literature DB >> 27469539

Stroke etiologic subtype may influence the rate of hyperdense middle cerebral artery sign disappearance after intravenous thrombolysis.

Stefano Forlivesi1, Paolo Bovi2, Giampaolo Tomelleri2, Nicola Micheletti2, Monica Carletti2, Giuseppe Moretto2, Manuel Cappellari2.   

Abstract

Disappearance of hyperdense middle cerebral artery sign (HMCAS) on non-contrast brain computed tomography (CT) scan is a reliable sign of arterial recanalization after intravenous (IV) thrombolysis for ischemic stroke. We aimed to assess whether stroke etiologic subtype may influence the rate of HMCAS disappearance and the clinical outcome after IV thrombolysis. We conducted a retrospective analysis of data prospectively collected from 1031 consecutive stroke patients treated with IV thrombolysis. Outcome measures were HMCAS disappearance on follow-up CT scan within 22-36 h of IV thrombolysis, neurologic improvement (NIH Stroke Scale [NIHSS] ≤4 points from baseline or NIHSS score of 0) at 7 days, and modified rankin scale (mRS) ≤1 at 3 months. Of 256 patients with HMCAS on admission CT scan, 125 had a cardioembolic stroke, 67 a stroke due to large-artery atherosclerosis (LAA), 58 a stroke of undetermined etiology, and six a stroke secondary to carotid artery dissection. HMCAS disappearance occurred in 145 (56.6 %) patients, neurologic improvement in 122 (55.0 %) patients, and mRS ≤1 in 64 (32.8 %) patients. Compared with cardioembolic stroke patients, patients with stroke due to LAA had lower odds ratios (OR) for HMCAS disappearance (OR 0.29, 95 % CI 0.15-0.58, p < 0.001), neurologic improvement (OR 0.42, 95 % CI 0.22-0.82, p = 0.011), and mRS ≤1 (OR 0.18, 95 % CI 0.06-0.52, p = 0.002). No significant differences in outcome measures were found between cardioembolic strokes and strokes of undetermined etiology. This study suggests that stroke due to LAA is associated with lower rates of HMCAS disappearance, neurologic improvement, and mRS ≤1 after IV thrombolysis, compared with cardioembolic stroke.

Entities:  

Keywords:  Cardioembolic stroke; Hyperdense middle cerebral artery; Large-artery atherosclerosis; Thrombolysis

Mesh:

Substances:

Year:  2017        PMID: 27469539     DOI: 10.1007/s11239-016-1404-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  18 in total

1.  Differentiation of white, mixed, and red thrombi: value of CT in estimation of the prognosis of thrombolysis phantom study.

Authors:  Klaus Kirchhof; Thomas Welzel; Cora Mecke; Saida Zoubaa; Klaus Sartor
Journal:  Radiology       Date:  2003-05-01       Impact factor: 11.105

Review 2.  Imaging of acute stroke.

Authors:  Keith W Muir; Alastair Buchan; Rudiger von Kummer; Joachim Rother; Jean-Claude Baron
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

3.  Tandem internal carotid artery/middle cerebral artery occlusion: an independent predictor of poor outcome after systemic thrombolysis.

Authors:  Marta Rubiera; Marc Ribo; Raquel Delgado-Mederos; Esteban Santamarina; Pilar Delgado; Joan Montaner; José Alvarez-Sabín; Carlos A Molina
Journal:  Stroke       Date:  2006-08-03       Impact factor: 7.914

4.  Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator.

Authors:  C Manelfe; V Larrue; R von Kummer; L Bozzao; P Ringleb; S Bastianello; F Iweins; E Lesaffre
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

5.  Quantification of thrombus hounsfield units on noncontrast CT predicts stroke subtype and early recanalization after intravenous recombinant tissue plasminogen activator.

Authors:  J Puig; S Pedraza; A Demchuk; J Daunis-I-Estadella; H Termes; G Blasco; G Soria; I Boada; S Remollo; J Baños; J Serena; M Castellanos
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-08       Impact factor: 3.825

6.  CT and MRI early vessel signs reflect clot composition in acute stroke.

Authors:  David S Liebeskind; Nerses Sanossian; William H Yong; Sidney Starkman; Michael P Tsang; Antonio L Moya; David D Zheng; Anna M Abolian; Doojin Kim; Latisha K Ali; Samir H Shah; Amytis Towfighi; Bruce Ovbiagele; Chelsea S Kidwell; Satoshi Tateshima; Reza Jahan; Gary R Duckwiler; Fernando Viñuela; Noriko Salamon; J Pablo Villablanca; Harry V Vinters; Victor J Marder; Jeffrey L Saver
Journal:  Stroke       Date:  2011-03-10       Impact factor: 7.914

7.  Histologic Analysis of Retrieved Clots in Acute Ischemic Stroke: Correlation with Stroke Etiology and Gradient-Echo MRI.

Authors:  S K Kim; W Yoon; T S Kim; H S Kim; T W Heo; M S Park
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-09       Impact factor: 3.825

8.  Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.

Authors:  T Kharitonova; M Thorén; N Ahmed; J M Wardlaw; R von Kummer; L Thomassen; N Wahlgren
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-10-17       Impact factor: 10.154

9.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

10.  Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Authors:  Grant Mair; Rüdiger von Kummer; Zoe Morris; Anders von Heijne; Nick Bradey; Lesley Cala; André Peeters; Andrew J Farrall; Alessandro Adami; Gillian Potter; Geoff Cohen; Peter A G Sandercock; Richard I Lindley; Joanna M Wardlaw
Journal:  Neurology       Date:  2015-12-09       Impact factor: 9.910

View more
  5 in total

Review 1.  Recanalisation therapy in patients with acute ischaemic stroke caused by large artery occlusion: choice of therapeutic strategy according to underlying aetiological mechanism?

Authors:  Chenglin Tian; Xiangyu Cao; Jun Wang
Journal:  Stroke Vasc Neurol       Date:  2017-08-01

Review 2.  Clinical Variables and Genetic Risk Factors Associated with the Acute Outcome of Ischemic Stroke: A Systematic Review.

Authors:  Nuria P Torres-Aguila; Caty Carrera; Elena Muiño; Natalia Cullell; Jara Cárcel-Márquez; Cristina Gallego-Fabrega; Jonathan González-Sánchez; Alejandro Bustamante; Pilar Delgado; Laura Ibañez; Laura Heitsch; Jerzy Krupinski; Joan Montaner; Joan Martí-Fàbregas; Carlos Cruchaga; Jin-Moo Lee; Israel Fernandez-Cadenas
Journal:  J Stroke       Date:  2019-09-30       Impact factor: 6.967

3.  FM Combined With NIHSS Score Contributes to Early AIS Diagnosis and Differential Diagnosis of Cardiogenic and Non-Cardiogenic AIS.

Authors:  Dan Wu; Yong'e Liu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

4.  Implications of the Presence of Hyperdense Middle Cerebral Artery Sign in Determining the Subtypes of Stroke Etiology.

Authors:  Suchada Sangpetch; Chayasak Wantaneeyawong; Atiwat Soontornpun; Nantaporn Tiyapun; Surat Tanprawate; Kitti Thiankhaw
Journal:  Stroke Res Treat       Date:  2021-11-17

5.  Value of repeated imaging in patients with a stroke who are transferred for endovascular treatment.

Authors:  Laura C C van Meenen; Nerea Arrarte Terreros; Adrien E Groot; Manon Kappelhof; Ludo F M Beenen; Henk A Marquering; Bart J Emmer; Yvo B W E M Roos; Charles B L M Majoie; Jonathan M Coutinho
Journal:  J Neurointerv Surg       Date:  2021-03-08       Impact factor: 5.836

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.